A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.
In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.
The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.
The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.
Beyond Backup Generators: Building Layered Energy Resilience
Shannon Health System to Acquire Scenic Mountain Medical Center
First Rehabilitation Resources Ensnared in Email Breach
Hand, Foot and Mouth Disease on the Rise
BayCare Reveals Pagidipati Children's Hospital at St. Joseph's